Vanda Pharmaceuticals
VNDA
£3.50
Share price
-0.43%
Change (1 day)
-25.02%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : £90.24 Million
According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are £90.24 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | £93.75 M | 15.38% |
| 2023-12-31 | £81.26 M | -8.16% |
| 2022-12-31 | £88.48 M | 34.41% |
| 2021-12-31 | £65.83 M | 11.9% |
| 2020-12-31 | £58.83 M | 5.96% |
| 2019-12-31 | £55.51 M | 24.28% |
| 2018-12-31 | £44.67 M | -18.45% |
| 2017-12-31 | £54.78 M | -14.48% |
| 2016-12-31 | £64.06 M | 18.63% |
| 2015-12-31 | £53.99 M | 672.22% |
| 2014-12-31 | £6.99 M | -88.38% |
| 2013-12-31 | £60.15 M | -22.56% |
| 2012-12-31 | £77.67 M | -19.05% |
| 2011-12-31 | £95.95 M | -15.53% |
| 2010-12-31 | £0.11 B | -9.3% |
| 2009-12-31 | £0.12 B | 4590.62% |
| 2008-12-31 | £2.67 M | -59.6% |
| 2007-12-31 | £6.61 M | 36.24% |
| 2006-12-31 | £4.85 M | 64.44% |
| 2005-12-31 | £2.95 M | 213.18% |
| 2004-12-31 | £0.94 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | £46.04 B | 50,920.17% | 🇨🇭 Switzerland |
 Eli Lilly LLY | £55.06 B | 60,921.08% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £86.53 B | 95,786.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | £56.14 B | 62,113.43% | 🇺🇸 USA |
 Pfizer PFE | £87.90 B | 97,304.56% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | £0.2 M | -99.77% | 🇺🇸 USA |
 Merck MRK | £49.96 B | 55,262.23% | 🇺🇸 USA |